Cline Christopher R. - Insider Transactions
Insider Type
individual
Companies
1
Average
22,275
Total Txns
13
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 5 | -5 | 0.00 | 74,244.39 | -74,244.39 |
| 2025 | 0 | 8 | -8 | 0.00 | 215,328.25 | -215,328.25 |
| Total: | 0 | 13 | 10 | 0.00 | 289,572.64 | -289,572.64 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
19.71 USD |
119 Sold |
2,345 USD |
03/09/2025 | 04/09/2025 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
18.20 USD |
454 Sold |
8,263 USD |
03/09/2025 | 03/09/2025 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
17.31 USD |
470 Sold |
8,136 USD |
27/08/2025 | 27/08/2025 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
21.05 USD |
1,784 Sold |
37,553 USD |
02/05/2025 | 05/05/2025 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
21.05 USD |
1,784 Sold |
37,553 USD |
02/05/2025 | 05/05/2025 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
13.14 USD |
48 Sold |
631 USD |
11/04/2025 | 11/04/2025 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
20.12 USD |
5,192 Sold |
104,463 USD |
31/01/2025 | 03/02/2025 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
18.94 USD |
865 Sold |
16,384 USD |
22/01/2025 | 22/01/2025 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
11.52 USD |
2,490 Sold |
28,685 USD |
05/09/2024 | 09/09/2024 |
| Travere Therapeutics, Inc. Common Stock US89422G1076 |
9.51 USD |
514 Sold |
4,888 USD |
04/09/2024 | 04/09/2024 |